Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 583

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 6
Chunk 583
---
. dollars per ADS. For purposes of this table, these share options are presented in the form of ordinary shares (with the corresponding number of ADSs where appropriate). Each ADS represents five ordinary shares.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
​

Long-Term Incentive Compensation
The following table sets forth information regarding performance based LTIP awards granted to our chief executive officer and chief scientific officer, chief financial officer and other executive officers on an aggregate basis in the year ended December 31, 2024.

                               ​                                  ​       ​            ​     
---------------------------------------------------------------------------------------------
​                                                                     Maximum                
​                                                                 ​   Aggregate              
​                                                                 ​   Value of               
Name and Principal Position                                       ​   LTIP awards(1)(2)(3)   
Weiguo SU, Chief Executive Officer and Chief Scientific Officer   ​   $3,348,180             
CHENG Chig Fung, Johnny, Chief Financial Officer                  ​   $759,951               
Other Executive Officers in the Aggregate                         ​   $1,848,800             
Notes:
​

(1)   The amounts reflected in the table above represent the maximum aggregate value of all LTIP awards outstanding as of December 31, 2024. The LTIP awards are conditional upon the achievement of annual performance targets for the fiscal year 2024, 2025 and 2026. The amounts reflected in the table above assume the maximum amount that may be paid under these contingent LTIP awards. The LTIP awards will be settled in a variable number of shares based on a fixed monetary amount awarded upon achievement of performance targets. An independent third-party trustee who administers the LTIP will purchase shares of our company on either the AIM or Nasdaq market which will be used to settle the LTIP awards. See “—Outstanding Awards and Grants of Awards” for more details.
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(2)   Vesting will occur in 2027, three weeks after the date of completion of the purchase of shares for the award relating to the Financial Year 2026.
-------------------------------------------------------------------------------------------------------------------------------------------------------

(3)   Excluding performance based LTIP awards abovementioned, a non-performance based LTIP award granted to an Executive Officer in an amount of $500,000, for which 79,652 ordinary shares were allocated on May 30, 2024. 25% of the shares were/will be vested on March 13, 2025, March 13, 2026, March 13, 202